ABL1 and acute lymphoblastic leukemia: The independent role of SFKs in B-ALL is further supported by results demonstrating that a SFK inhibitor reduced the viability, and induced apoptosis, in pre-B leukemia cells expressing the imatinib-resistant T315I BCR-ABL mutant [25].